Aurobindo Pharma

quarterly
yearly
ParticularsMar '25Jun '25Sep '25Dec '25Mar '26
Revenue8,5177,9738,4068,8348,970
Expenses7,1506,7697,1327,4307,677
EBITDA1,9271,7081,7991,9611,870
Operating Profit1,4501,3051,3711,4311,389
Profit Before Tax1,3351,2071,2761,3391,291
Net Profit902.83824.20848.13909.80920.84
Financial Ratios
Operating Profit Margin22.60%21.95%21.86%22.04%21.34%
Net Profit Margin10.78%10.58%10.30%11.10%10.53%
Earning Per Share (Diluted)15.5614.2014.6115.6715.86
Dividends Per Share0.004.000.000.000.00